ArticleScientific reports2025

Chimeric SF-25 monoclonal antibody as a targeted therapy for SLC3A2 in adult T-cell leukemia/lymphoma.

Shinsuke Suzuki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.